Advanced and experienced hematology and cancer care.
Anemia

Phase 3 study investigating the efficacy and safety of roxadustat for treatment of anemia in patients with lower risk Myelodysplastic Syndrome (MDS) and low Red Blood Cell (RBC) transfusion burden.

By Adam Lingle | Posted in Clinical Trials | Leave a comment

Subscribe to our Newsletter!

Signup today for free and be the first to get notified on new updates.